A Randomized，Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 with Bevacizumab  (Avastin®) in Chinese Healthy Male Subjects

Original Research Article：

Frontiers in Pharmacology

https://doi: 10.3389/fphar.2021.694375